427 related articles for article (PubMed ID: 3474081)
1. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Periti P; Mazzei T; Nicoletti P
Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
[TBL] [Abstract][Full Text] [Related]
2. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of piperacillin/quinolone combinations].
Soussy CJ; Leclercq R; Duval J
Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
[TBL] [Abstract][Full Text] [Related]
5. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
[TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
12. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity of 7 mycobacterial species to new quinolones].
Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
[TBL] [Abstract][Full Text] [Related]
14. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
Thabaut A; Meyran M; Fabre R; Dellamonica P; Moreau N
Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
16. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
17. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Texier-Maugein J; Mormède M; Fourche J; Bébéar C
Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]